121 related articles for article (PubMed ID: 2902095)
1. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
Boarer CD; Sojka MG; White VJ; Roeder PL
J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
[TBL] [Abstract][Full Text] [Related]
2. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
[TBL] [Abstract][Full Text] [Related]
3. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
Hauer PJ; Clough NE
Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
[TBL] [Abstract][Full Text] [Related]
4. Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.
Uzal FA; Nielsen K; Kelly WR
Vet Microbiol; 1997 Sep; 57(2-3):223-31. PubMed ID: 9355257
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
McClain MS; Cover TL
Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli.
Goswami PP; Rupa P; Prihar NS; Garg LC
Biochem Biophys Res Commun; 1996 Sep; 226(3):735-40. PubMed ID: 8831683
[TBL] [Abstract][Full Text] [Related]
8. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
Naylor RD; Martin PK; Barker LT
Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
[TBL] [Abstract][Full Text] [Related]
9. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against alpha toxin of Clostridium perfringens.
Sato H; Chiba J; Sato Y
FEMS Microbiol Lett; 1989 May; 50(1-2):173-6. PubMed ID: 2544482
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens.
Lee KW; Lillehoj HS; Park MS; Jang SI; Ritter GD; Hong YH; Jeong W; Jeoung HY; An DJ; Lillehoj EP
Avian Dis; 2012 Mar; 56(1):230-3. PubMed ID: 22545552
[TBL] [Abstract][Full Text] [Related]
12. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
Rosskopf-Streicher U; Volkers P; Werner E
Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
[TBL] [Abstract][Full Text] [Related]
13. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
[TBL] [Abstract][Full Text] [Related]
14. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
Ebert E; Oppling V; Werner E; Cussler K
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
Bentancor AB; Halperin P; Flores M; Iribarren F
J Infect Dev Ctries; 2009 Sep; 3(8):624-7. PubMed ID: 19801806
[TBL] [Abstract][Full Text] [Related]
16. Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.
Sayeed S; Fernandez-Miyakawa ME; Fisher DJ; Adams V; Poon R; Rood JI; Uzal FA; McClane BA
Infect Immun; 2005 Nov; 73(11):7413-21. PubMed ID: 16239541
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of various enzyme-linked immunosorbent assays for the detection of Clostridium perfringens beta anti-toxins.
Krt B
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):293-7. PubMed ID: 10397314
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of antibodies to Clostridium perfringens epsilon toxin from hyperimmune horse serum.
Worthington RW; Mülders MS
Onderstepoort J Vet Res; 1979 Sep; 46(3):121-4. PubMed ID: 233148
[TBL] [Abstract][Full Text] [Related]
20. Development of double sandwich ELISA for Clostridium perfringens beta and epsilon toxins.
el Idrissi AH; Ward GE
Vet Microbiol; 1992 Apr; 31(1):89-99. PubMed ID: 1615638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
